UK, Eli Lilly to trial use of weight loss drugs to combat unemployment

UK, Eli Lilly to trial use of weight loss drugs to combat unemployment

LONDON — U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K. The weight-loss treatment firm and creator of Zepbound announced Monday that it would commit £279 million ($364 million) to help tackle Britain’s significant health challenges — including obesity. … Read more

Novo and Lilly contender Zealand Pharma targets ‘next generation’ of obesity drugs

Novo and Lilly contender Zealand Pharma targets ‘next generation’ of obesity drugs

Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly. CEO Adam Steensberg told CNBC Thursday that early-stage trials of its experimental obesity injection point to higher-quality weight loss — with reduced muscle loss and fewer side effects — … Read more

AstraZeneca shares fall 5% on disappointing lung cancer drug trial

AstraZeneca shares fall 5% on disappointing lung cancer drug trial

An illustrative image of a person holding a medical syringe and a Covid-19 vaccine vial in front of the the AstraZeneca logo displayed on a screen. On Wednesday, January 12, 2021, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images AstraZeneca shares fell more than 5% Tuesday … Read more

Bayer shares soar after U.S. legal win against Roundup cancer claims

Bayer shares soar after U.S. legal win against Roundup cancer claims

CHICAGO, ILLINOIS – MAY 14: Roundup weed killing products are offered for sale at a home improvement store on May 14, 2019 in Chicago, Illinois. A jury yesterday ordered Monsanto, the maker of Roundup, to pay a California couple more than $2 billion in damages after finding that the weed killer had caused their cancer. … Read more

Novo Nordisk’s Wegovy wins EU backing for reducing heart risks

Novo Nordisk’s Wegovy wins EU backing for reducing heart risks

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Novo Nordisk’s blockbuster Wegovy weight loss drug has received backing from the European Union’s medical regulator to expand the medicine’s use to include reducing the rise of serious heart events in overweight and obese adults. The Danish … Read more

Novo Nordisk’s Wegovy weight loss drug approved in China

Novo Nordisk’s Wegovy weight loss drug approved in China

Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity.  Nurphoto | Getty Images Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world’s second largest economy. China’s National Medical Products Administration “recently” … Read more

AstraZeneca to withdraw Covid vaccine worldwide, citing drop in demand

AstraZeneca to withdraw Covid vaccine worldwide, citing drop in demand

In this photo illustration a covid-19 vaccine is seen with the AstraZeneca logo in the background. (Photo Illustration by Nikos Pekiaridis/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined. Demand for AstraZeneca’s Vaxzevria vaccine began … Read more

Wegovy maker Novo Nordisk extends losses following first-quarter results

Wegovy maker Novo Nordisk extends losses following first-quarter results

Shares of Danish pharmaceutical giant Novo Nordisk slid 2.5% on Friday, extending a 2.7% loss on Thursday as analysts pored over the details of the firm’s first-quarter results and monitored a potential rival weight loss treatment. The company reported that sales for its blockbuster injectable weight loss treatment Wegovy, more than doubled to 9.38 billion Danish kroner ($1.4 … Read more

Swiss pharma giant Roche’s first-quarter sales edge higher as its emerges from post-Covid-19 slump

Swiss pharma giant Roche’s first-quarter sales edge higher as its emerges from post-Covid-19 slump

A logo at the Roche Holding AG headquarters in Basel, Switzerland, on Thursday, Feb. 1, 2024. Bloomberg | Getty Images Swiss pharmaceutical company Roche on Wednesday reported a modest uptick in first-quarter sales, even as waning demand for its Covid-19 products continued to weigh on the company. Sales were up 2% at constant exchange rates, … Read more

How this UK-based firm is growing a more sustainable cannabis

How this UK-based firm is growing a more sustainable cannabis

Cannabis plants grow in the clone room at Aurora Deutschland GmbH, a manufacturer of medical Cannabis products, in Leuna, Germany September 11, 2023. Lisi Niesner | Reuters Growing cannabis indoors uses a lot of energy, obviously resulting in higher emissions. But some companies are trying to combat that like U.K.-based cultivator Glass Pharms. It claims … Read more